Santini D - Search Results

1

Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?

Aprile G, Negri FV, Giuliani F, De Carlo E, Melisi D, Simionato F, Silvestris N, Brunetti O, Leone F, Marino D, Santini D, Dell'Aquila E, Zeppola T, Puzzoni M, Scartozzi M. Aprile G, et al. Among authors: santini d. Crit Rev Oncol Hematol. 2017 Jul;115:1-12. doi: 10.1016/j.critrevonc.2017.03.025. Epub 2017 Apr 20. Crit Rev Oncol Hematol. 2017. PMID: 28602164 Review.

2

Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancer: a multicenter non-randomized phase ii study.

Santini D, Massacesi C, D'Angelillo RM, Marcucci F, Campisi C, Vincenzi B, Pilone A, Bianco V, Bonsignori M, Tonini G. Santini D, et al. Among authors: d angelillo rm. Med Oncol. 2004;21(1):59-66. doi: 10.1385/MO:21:1:59. Med Oncol. 2004. PMID: 15034215 Clinical Trial.

3

Predictive factors for response to chemotherapy in colorectal cancer patients.

Vincenzi B, Cesa AL, Santini D, Schiavon G, Grilli C, Graziano F, Tonini G. Vincenzi B, et al. Among authors: santini d. Crit Rev Oncol Hematol. 2004 Oct;52(1):45-60. doi: 10.1016/j.critrevonc.2004.05.005. Crit Rev Oncol Hematol. 2004. PMID: 15363466 Review.

4

Thymidylate synthase expression in normal colonic mucosa: a predictive marker of toxicity in colorectal cancer patients receiving 5-fluorouracil-based adjuvant chemotherapy.

Santini D, Vincenzi B, Perrone G, Rabitti C, Borzomati D, Caricato M, La Cesa A, Grilli C, Verzì A, Coppola R, Tonini G. Santini D, et al. Oncology. 2004;67(2):135-42. doi: 10.1159/000081000. Oncology. 2004. PMID: 15539918

5

Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer.

Graziano F, Ruzzo A, Santini D, Humar B, Tonini G, Catalano V, Berardi R, Pizzagalli F, Arduini F, Bearzi I, Scartozzi M, Cascinu S, Testa E, Ficarelli R, Magnani M. Graziano F, et al. Among authors: santini d. J Clin Oncol. 2005 Apr 1;23(10):2339-45. doi: 10.1200/JCO.2005.02.345. J Clin Oncol. 2005. PMID: 15800325 Clinical Trial.

6

Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients.

Santini D, Vincenzi B, La Cesa A, Caricato M, Schiavon G, Spalletta B, Di Seri M, Coppola R, Rocci L, Tonini G. Santini D, et al. Oncology. 2005;69(1):27-34. doi: 10.1159/000087285. Epub 2005 Jul 28. Oncology. 2005. PMID: 16088232

7

A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC).

Giorgio CG, Pappalardo A, Russo A, Giuffrida D, Santini D, Petralia G, Castorina S, Nunzio R, Failla G, Bordonaro R. Giorgio CG, et al. Among authors: santini d. Lung Cancer. 2006 Mar;51(3):357-62. doi: 10.1016/j.lungcan.2005.10.023. Epub 2006 Jan 9. Lung Cancer. 2006. PMID: 16406602 Clinical Trial.

8

Phase I study of intermittent and chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer.

Santini D, Vincenzi B, Schiavon G, La Cesa A, Gasparro S, Vincenzi A, Tonini G. Santini D, et al. BMC Cancer. 2006 Feb 24;6:42. doi: 10.1186/1471-2407-6-42. BMC Cancer. 2006. PMID: 16504126 Free PMC article. Clinical Trial.

9

Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy.

Ruzzo A, Graziano F, Kawakami K, Watanabe G, Santini D, Catalano V, Bisonni R, Canestrari E, Ficarelli R, Menichetti ET, Mari D, Testa E, Silva R, Vincenzi B, Giordani P, Cascinu S, Giustini L, Tonini G, Magnani M. Ruzzo A, et al. Among authors: santini d. J Clin Oncol. 2006 Apr 20;24(12):1883-91. doi: 10.1200/JCO.2005.04.8322. J Clin Oncol. 2006. PMID: 16622263

10

Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study.

Santini D, Vincenzi B, Schiavon G, Di Seri M, Virzí V, Spalletta B, Caricato M, Coppola R, Tonini G. Santini D, et al. Cancer Chemother Pharmacol. 2007 Apr;59(5):613-20. doi: 10.1007/s00280-006-0302-x. Epub 2006 Aug 31. Cancer Chemother Pharmacol. 2007. PMID: 16944151 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,087 results

Search Page